Go to home page - Ministry of HealthWhats New - Ministry of HealthPublications - Ministry of HealthForums - Ministry of HealthLinks - Ministry of HealthContact - Ministry of HealthAbout - Ministry of HealthSearch - Ministry of HealthSkip Navigation
Print this  Email this
  • Home
  • About Immunisation
  • New Zealand Immunisation Schedule
  • Diseases and Vaccines
  • Immunisation Coverage
  • National Immunisation Register
  • Immunisation eLearning
  • Vaccine Safety
  • News and Updates
  • Publications
  • Information for Health Professionals
  • Useful Links

Immunisation

Rubella


Back to the Diseases and Vaccines page

Rubella is serious if a pregnant woman catches the disease, especially during the first three months of her pregnancy. A mother can pass rubella on to her unborn baby. All women of child-bearing age should be screened for rubella antibodies and immunised where necessary prior to pregnancy. The test and vaccine is free to women.


Virus

Rubella is a mild viral illness. A few cases of rubella occur in New Zealand each year.

Vaccine

This disease is covered on the New Zealand Immunisation Schedule. The vaccine used is M-M-R® II.

How it is spread

It is spread through the air by breathing, coughing and sneezing.

Symptoms and illness

Rubella may cause a mild illness with a rash, fever and swollen glands in children. In teenagers and adults it may cause a rash, swollen glands and joint pain.

Severe risks associated with rubella

  • For women in early pregnancy, 85% of babies infected during the first eight weeks after conception will have a major congenital abnormality such as deafness, blindness, brain damage, or a heart defect. This declines to about 10–20% by 16 weeks of the pregnancy.
  • About one in 3000 patients gets thrombocytopaenia (low platelets causing bruising or bleeding).
  • One in 6000 develops encephalitis (inflammation of the brain). This usually occurs in young adults. This may result in death.

Severe risks associated with the vaccine

  • Joint symptoms may occur in 0–3 in 100 children. This is mild and short-lasting.

Back to the Diseases and Vaccines page

Website feedback
We welcome your feedback on this page.

Page last updated: 13 June 2008



Privacy | Copyright | Disclaimer | About Us | Access Keys | Feedback | Contact Us | Employment | newzealand.govt.nz